TP53 and head and neck cancer: A quick and easy method for identifying head and neck cancer patients who are more likely to develop SPTs is immunohistochemistry labeling for p53 overexpression in tumor-distant epithelia; however, the accuracy of similar diagnostic techniques is still under investigation to assess their sensitivity and specificity [35,36].